2026 Global: Cardiac Surgical Devices Market-Competitive Review (2032) report
Description
The 2026 Global: Cardiac Surgical Devices Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cardiac surgical devices market by geography and historical trend. The scope of the report extends to sizing of the cardiac surgical devices market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, Johnson & Johnson (Ethicon and other J&J MedTech units), and Stryker are among the major players dominating the cardiac surgical devices market with broad portfolios spanning heart valves, surgical instruments, circulatory support, and imaging-guided therapy systems. Medtronic’s cardiac surgical footprint includes surgical and transcatheter heart valves, cardiac rhythm management tools and extracorporeal circulation technologies that support open and minimally invasive procedures. Abbott’s offerings encompass structural heart devices, mitral and transcatheter valve technologies, left atrial appendage closure and intraoperative monitoring systems used in cardiac surgery and hybrid cath‑lab/OR procedures. Boston Scientific supplies structural heart products, vascular and electrophysiology devices that integrate into surgical workflows for complex coronary and structural interventions. Edwards Lifesciences is focused on surgical and transcatheter heart valve therapies, surgical repair systems and hemodynamic monitoring solutions that are staples in valve replacement and repair surgeries. Johnson & Johnson’s MedTech businesses provide surgical stapling, advanced tissue repair, and cardiovascular implants together with capital equipment and disposables used in cardiac operating rooms. Stryker, while better known for orthopedics, contributes surgical visualization, robotics and advanced instrumentation that increasingly support cardiothoracic procedures and hybrid OR setups.
Getinge, LivaNova (including legacy Sorin/Livanova cardiac surgery lines), Atrion, and GE HealthCare round out other leading suppliers that supply perfusion systems, heart–lung machines, cardiopulmonary bypass disposables, and intraoperative monitoring platforms central to cardiac surgery. Getinge is a global supplier of perfusion systems, surgical tables, and critical‑care devices used throughout cardiothoracic suites and intensive care units. LivaNova’s heritage in cardiopulmonary bypass, neuro and cardiac rhythm management positions it as a specialist in devices for open heart surgery, myocardial protection and extracorporeal circulation. Atrion manufactures pressure regulators, distillation and fluid‑management components and surgical consumables used in cardiothoracic procedures and perfusion setups. GE HealthCare supplies advanced imaging, angiography and hemodynamic monitoring systems that enable intraoperative guidance, hybrid procedures and post‑operative surveillance in cardiac surgical care. Collectively these ten companies supply the full procedural ecosystem—implants and prostheses, bypass and perfusion hardware, imaging and monitoring, surgical instrumentation and disposables—driving innovation toward less invasive approaches, better intraoperative visualization, integrated data/monitoring platforms and modular hybrid OR capabilities that aim to reduce operative risk and improve valve and coronary procedure outcomes.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for cardiac surgical devices market by geography and historical trend. The scope of the report extends to sizing of the cardiac surgical devices market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, Johnson & Johnson (Ethicon and other J&J MedTech units), and Stryker are among the major players dominating the cardiac surgical devices market with broad portfolios spanning heart valves, surgical instruments, circulatory support, and imaging-guided therapy systems. Medtronic’s cardiac surgical footprint includes surgical and transcatheter heart valves, cardiac rhythm management tools and extracorporeal circulation technologies that support open and minimally invasive procedures. Abbott’s offerings encompass structural heart devices, mitral and transcatheter valve technologies, left atrial appendage closure and intraoperative monitoring systems used in cardiac surgery and hybrid cath‑lab/OR procedures. Boston Scientific supplies structural heart products, vascular and electrophysiology devices that integrate into surgical workflows for complex coronary and structural interventions. Edwards Lifesciences is focused on surgical and transcatheter heart valve therapies, surgical repair systems and hemodynamic monitoring solutions that are staples in valve replacement and repair surgeries. Johnson & Johnson’s MedTech businesses provide surgical stapling, advanced tissue repair, and cardiovascular implants together with capital equipment and disposables used in cardiac operating rooms. Stryker, while better known for orthopedics, contributes surgical visualization, robotics and advanced instrumentation that increasingly support cardiothoracic procedures and hybrid OR setups.
Getinge, LivaNova (including legacy Sorin/Livanova cardiac surgery lines), Atrion, and GE HealthCare round out other leading suppliers that supply perfusion systems, heart–lung machines, cardiopulmonary bypass disposables, and intraoperative monitoring platforms central to cardiac surgery. Getinge is a global supplier of perfusion systems, surgical tables, and critical‑care devices used throughout cardiothoracic suites and intensive care units. LivaNova’s heritage in cardiopulmonary bypass, neuro and cardiac rhythm management positions it as a specialist in devices for open heart surgery, myocardial protection and extracorporeal circulation. Atrion manufactures pressure regulators, distillation and fluid‑management components and surgical consumables used in cardiothoracic procedures and perfusion setups. GE HealthCare supplies advanced imaging, angiography and hemodynamic monitoring systems that enable intraoperative guidance, hybrid procedures and post‑operative surveillance in cardiac surgical care. Collectively these ten companies supply the full procedural ecosystem—implants and prostheses, bypass and perfusion hardware, imaging and monitoring, surgical instrumentation and disposables—driving innovation toward less invasive approaches, better intraoperative visualization, integrated data/monitoring platforms and modular hybrid OR capabilities that aim to reduce operative risk and improve valve and coronary procedure outcomes.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
